Cat. No.: X24-08-YM083
DNA-RNA synthesis inhibitor, Daptomycin, Purity ≥98%
Synonym: 103060-53-3; Cubicin; (3S)-3-[[(2R)-4-Amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid
- CAS Number: 103060-53-3
- Compound CID: 21585658
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Properties
Description
Daptomycin, soluble in DMSO and warmed water and insoluble in ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis.
Molecular Formula
C72H101N17O26
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 87 mg/mL (53.68 mM); Water (warmed): 87 mg/mL (53.68 mM); Ethanol: insoluble
Applications
Daptomycin is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
Related Products
- DNA-RNA synthesis inhibitor, Cidofovir, Purity ≥98%
- DNA-RNA synthesis inhibitor, Clafen, Purity ≥98%
- DNA-RNA synthesis inhibitor, Dacarbazine, Purity ≥98%
- DNA-RNA synthesis inhibitor, Gemcitabine HCl, Purity ≥98%
- DNA-RNA synthesis inhibitor, Ifosfamide, Purity ≥98%
- DNA-RNA synthesis inhibitor, Lincomycin hydrochloride, Purity ≥98%
